Characteristics and outcomes of ambulatory patients with suspected COVID-19 at a respiratory referral center.


Journal

Respiratory medicine
ISSN: 1532-3064
Titre abrégé: Respir Med
Pays: England
ID NLM: 8908438

Informations de publication

Date de publication:
06 2022
Historique:
received: 17 11 2021
revised: 28 03 2022
accepted: 29 03 2022
pubmed: 25 4 2022
medline: 18 5 2022
entrez: 24 4 2022
Statut: ppublish

Résumé

SARS-CoV-2 continues to cause a global pandemic and management of COVID-19 in outpatient settings remains challenging. We sought to describe characteristics of patients with chronic respiratory disease (CRD) experiencing symptoms consistent with COVID-19, who were seen in a novel Acute Respiratory Clinic, prior to widely available testing, emergence of variants, COVID-19 vaccination, and post-vaccination (breakthrough) SARS-CoV-2 infections. Retrospective electronic medical record data were analyzed from 907 adults with presumed COVID-19 seen between March 16, 2020 and January 7, 2021. Data included demographics, comorbidities, medications, vital signs, laboratory tests, pulmonary function tests, patient disposition, and co-infections. The overdispersed data (aod) R package was used to create a logit model using COVID-19 diagnosis by PCR as the dichotomous outcome variable. Univariate, conventional multivariate and elastic net machine learning were used to analyze data. Male gender, elevated baseline temperature, and respiratory rate predicted COVID-19 diagnosis. Eosinopenia, neutrophilia, and lymphocytosis were also associated with COVID-19 diagnosis. However, asthma and COPD diagnoses were not associated with SARS-CoV-2 PCR positive test. Male gender, low oxygen saturation, and lower forced expiratory volume in 1 s (FEV CRD patients with acute respiratory symptoms in the ambulatory setting were more likely to have COVID-19 if male, febrile and tachypneic. Patients with lower pre-morbid FEV

Identifiants

pubmed: 35462298
pii: S0954-6111(22)00097-X
doi: 10.1016/j.rmed.2022.106832
pmc: PMC8986541
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106832

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Références

J Am Board Fam Med. 2021 Feb;34(Suppl):S113-S126
pubmed: 33622826
Int J Gen Med. 2021 Apr 28;14:1555-1563
pubmed: 33953603
Nat Med. 2021 Jun;27(6):1055-1061
pubmed: 33875890
Public Health Rep. 2021 May;136(3):345-353
pubmed: 33541222
PLoS One. 2020 Nov 12;15(11):e0242182
pubmed: 33180868
Am J Transplant. 2021 Aug;21(8):2762-2773
pubmed: 33811777
J Allergy Clin Immunol. 2020 Jul;146(1):80-88.e8
pubmed: 32422146
J Clin Med. 2020 Nov 20;9(11):
pubmed: 33233575
Allergy. 2020 Sep;75(9):2405-2408
pubmed: 32506509
Arch Med Res. 2021 May;52(4):443-449
pubmed: 33380361
Aging Clin Exp Res. 2020 Oct;32(10):2133-2140
pubmed: 32918696
J Allergy Clin Immunol. 2020 Jul;146(1):203-206.e3
pubmed: 32333915
Eur Respir J. 2020 May 7;55(5):
pubmed: 32269088
Ann Rheum Dis. 2020 Nov;79(11):1393-1399
pubmed: 32769150
Lancet. 2002 Mar 9;359(9309):831-4
pubmed: 11897281
Clin Infect Dis. 2021 Dec 16;73(12):2257-2264
pubmed: 33515252
JAMA Netw Open. 2020 Oct 1;3(10):e2025197
pubmed: 33084902
BMC Infect Dis. 2021 Jan 9;21(1):40
pubmed: 33421991
Mayo Clin Proc. 2021 Apr;96(4):921-931
pubmed: 33814092
JAMA. 2021 Feb 16;325(7):632-644
pubmed: 33475701
N Engl J Med. 2021 Dec 2;385(23):e81
pubmed: 34587383
JAMA. 2022 Feb 1;327(5):432-441
pubmed: 35029629
N Engl J Med. 2021 Nov 18;385(21):1941-1950
pubmed: 34706189
J Allergy Clin Immunol Pract. 2021 Feb;9(2):684-692.e1
pubmed: 33242628
J Allergy Clin Immunol. 2021 Aug;148(2):361-367.e13
pubmed: 34144110
Diabetes Care. 2020 Oct;43(10):2339-2344
pubmed: 32769128
Am J Respir Crit Care Med. 2020 Jul 1;202(1):8-10
pubmed: 32437628
N Engl J Med. 2021 Oct 7;385(15):1382-1392
pubmed: 34260849
Emerg Med J. 2021 Apr;38(4):304-307
pubmed: 33602725
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632

Auteurs

Vamsi P Guntur (VP)

Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, USA; The NJH Cohen Family Asthma Institute, National Jewish Health, Denver, CO, USA; Division of Pulmonary Sciences and Critical Care Medicine, School of Medicine, University of Colorado, Denver, CO, USA. Electronic address: Gunturv@njhealth.org.

Brian D Modena (BD)

Modena Allergy & Asthma, La Jolla, CA, USA.

Laurie A Manka (LA)

Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, USA; The NJH Cohen Family Asthma Institute, National Jewish Health, Denver, CO, USA.

Jared J Eddy (JJ)

Division of Mycobacterial and Respiratory Infections, National Jewish Health, Denver, CO, USA.

Shu-Yi Liao (SY)

Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, USA.

Nir M Goldstein (NM)

Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, USA.

Pearlanne Zelarney (P)

Research Informatics Services, National Jewish Health, Denver, CO, USA.

Carrie A Horn (CA)

Division of Hospital & Internal Medicine, National Jewish Health, Denver, CO, USA.

Rebecca C Keith (RC)

Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, USA; Division of Pulmonary Sciences and Critical Care Medicine, School of Medicine, University of Colorado, Denver, CO, USA.

Barry J Make (BJ)

Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, USA; Division of Pulmonary Sciences and Critical Care Medicine, School of Medicine, University of Colorado, Denver, CO, USA.

Irina Petrache (I)

Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, USA; Division of Pulmonary Sciences and Critical Care Medicine, School of Medicine, University of Colorado, Denver, CO, USA.

Michael E Wechsler (ME)

Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, USA; The NJH Cohen Family Asthma Institute, National Jewish Health, Denver, CO, USA; Division of Pulmonary Sciences and Critical Care Medicine, School of Medicine, University of Colorado, Denver, CO, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH